Biotech | March 20, 2024
Lonza to buy US biologics site from Roche for US$ 1.2 billion
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Lonza plans to invest approximately CHF 500 million to upgrade the facility
A five-day inspection was concluded successfully with no critical and no major observations raised
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
Acquisition of exclusive commercialization rights for European markets
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
BHL will undertake the development and supply of these molecules
Subscribe To Our Newsletter & Stay Updated
